Kirin sets 300bn yen revenue goal for health science business
Kirin has outlined a series of initiatives that will combine its strengths, as well as that of subsidiaries FANCL and Blackmores, in achieving a revenue of 300bn yen (US$1.95bn) for its health science business by 2030.